Bruxism is a sleep related movement disorder defined by repetitive jaw muscle activity that causes clenching or grinding of the teeth. Bruxism can lead to teeth and jaw damage and disturbs sleeping process. Although gastro-esophageal reflux, smoking and disturbances in CNS dopaminergic system implicated in etiology of bruxism but no clear etiology is defined. There are plenty of treatments were used for these patients included biofeedback, hypnosis, occlusal splints, beside drugs. Pharmacological treatments such as Clonidine, Clonazepam, Hydroxizine, Sodium valproate, selective serotonin reuptake inhibitors (SSRIs) sometimes induce bruxism. Case reports showed that SSRIs induced bruxism resolved by Buspirone but tricyclic antidepressants were not supported to be effective treatment for bruxism in papers. It is hypothesized that the direct and indirect pathways of the basal ganglia are involved in the coordination of movements is disturbed in bruxer like in Parkinson disease. Based on these facts we had thought Trihexyphenidyl may be effective in resistant patients. This study describes 4 patients whom suffered from bruxism which resisted to usual treatments. Trihexiphenidyl (Artane) an anticholinergic drug reduced symptoms in all cases. Anticholinergic drugs can be considered for treating bruxism. Both night and day types of bruxism, as a movement disorder was relieved in response to Thp, probably due to anticholinergic effects in basal ganglia. These isolated cases could not be generalized. Further placebo controlled clinical trials are needed to evaluate and proof the efficacy of anticholinergic drugs such as Thp for treating of bruxism.
| Published in | American Journal of Psychiatry and Neuroscience (Volume 3, Issue 6) |
| DOI | 10.11648/j.ajpn.20150306.12 |
| Page(s) | 108-110 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Anticholinergic, Bruxism Treatment, Trihexiphenidyl
| [1] | Lobbezoo, F., et al., Bruxism defined and graded: an international consensus. J Oral Rehabil, 2013. 40(1): 2-4. doi: 10.1111/joor.12011. PMID: 23121262. |
| [2] | Carra, M.C., et al., Sleep bruxism, snoring, and headaches in adolescents: short-term effects of a mandibular advancement appliance. Sleep Med, 2013. 14(7):656-61.doi: 10.1016/j.sleep.2013.03.009. PMID: 23643652. |
| [3] | Fernandes, G., et al., Temporomandibular disorders, sleep bruxism, and primary headaches are mutually associated. J Orofac Pain, 2013. 27(1):14-20. doi: 10.11607/jop.921. PMID: 23424716 |
| [4] | Cheifetz, A.T., et al., Prevalence of bruxism and associated correlates in children as reported by parents. J Dent Child (Chic), 2005. 72(2):67-73. PMCID: PMC3446016. |
| [5] | Manfredini, D., et al., Epidemiology of bruxism in adults: a systematic review of the literature. J Orofac Pain, 2013. 27(2):99-110. .doi:10.11607/jop.921 |
| [6] | Feu, D., et al., A systematic review of etiological and risk factors associated with bruxism. J Orthod, 2013. 40(2):63-71. doi: 10.1179/1465313312Y.0000000021. PMID: 23794697. |
| [7] | Chen, W.H., et al., A proposed mechanism for diurnal/nocturnal bruxism: hypersensitivity of presynaptic dopamine receptors in the frontal lobe. J Clin Neurosci, 2005. 12(2):161-3. PMID: 15749418. |
| [8] | Ilovar, S., et al., Biofeedback for treatment of awake and sleep bruxism in adults: systematic review protocol. Syst Rev, 2014. 3:42. doi: 10.1186/2046-4053-3-42. |
| [9] | Dowd, E.T., Nocturnal bruxism and hypnotherapy: a case study. Int J Clin Exp Hypn, 2013. 61(2):205-18. doi: 10.1080/00207144.2013.753832. PMID: 23427844. |
| [10] | Macedo, C.R., et al., Pharmacotherapy for sleep bruxism. Cochrane Database Syst Rev, 2014. 10:Cd005578. doi: 10.1002/14651858.CD005578.pub2. PMID: 25338726. |
| [11] | Huynh, N.T., et al., Comparison of various treatments for sleep bruxism using determinants of number needed to treat and effect size. Int J Prosthodont, 2006. 19(5):435-41. PMID: 17323720. |
| [12] | Sabuncuoglu, O., O. Ekinci, and M. Berkem, Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report. Spec Care Dentist, 2009. 29(5):215-7.doi: 10.1111/j.1754-4505.2009.00091.x. PMID: 19740153. |
| [13] | Raigrodski, A.J., et al., The effect of four-week administration of amitriptyline on sleep bruxism. A double-blind crossover clinical study. Cranio, 2001. 19(1):21-5.PMID: 11842836. |
| [14] | Webster, J.B., C.E. Poorman, and D.X. Cifu, Guest editorial: Botulinum toxin injection for bruxism associated with brain injury: case report. J Rehabil Res Dev, 2014. 51(4):vii-xvi. doi: 10.1682/JRRD.2013.10.0218. PMID: 25144179. |
| [15] | Srivastava, T., et al., Bruxism as presenting feature of Parkinson's disease. J Assoc Physicians India, 2002. 50:457. PMID: 11922248. |
| [16] | Lavigne, G.J., et al., Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med, 2003. 14(1):30-46. PMID: 12764018. |
APA Style
Seyyed Mohammad Moosavi, Javad Setareh, Mahshid Ahmadi, Mani B. Monajemi, Soudabeh Shafiee Ardestani. (2015). Treatment of Bruxism with Trihexiphenidyl, a Case Series. American Journal of Psychiatry and Neuroscience, 3(6), 108-110. https://doi.org/10.11648/j.ajpn.20150306.12
ACS Style
Seyyed Mohammad Moosavi; Javad Setareh; Mahshid Ahmadi; Mani B. Monajemi; Soudabeh Shafiee Ardestani. Treatment of Bruxism with Trihexiphenidyl, a Case Series. Am. J. Psychiatry Neurosci. 2015, 3(6), 108-110. doi: 10.11648/j.ajpn.20150306.12
AMA Style
Seyyed Mohammad Moosavi, Javad Setareh, Mahshid Ahmadi, Mani B. Monajemi, Soudabeh Shafiee Ardestani. Treatment of Bruxism with Trihexiphenidyl, a Case Series. Am J Psychiatry Neurosci. 2015;3(6):108-110. doi: 10.11648/j.ajpn.20150306.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajpn.20150306.12,
author = {Seyyed Mohammad Moosavi and Javad Setareh and Mahshid Ahmadi and Mani B. Monajemi and Soudabeh Shafiee Ardestani},
title = {Treatment of Bruxism with Trihexiphenidyl, a Case Series},
journal = {American Journal of Psychiatry and Neuroscience},
volume = {3},
number = {6},
pages = {108-110},
doi = {10.11648/j.ajpn.20150306.12},
url = {https://doi.org/10.11648/j.ajpn.20150306.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajpn.20150306.12},
abstract = {Bruxism is a sleep related movement disorder defined by repetitive jaw muscle activity that causes clenching or grinding of the teeth. Bruxism can lead to teeth and jaw damage and disturbs sleeping process. Although gastro-esophageal reflux, smoking and disturbances in CNS dopaminergic system implicated in etiology of bruxism but no clear etiology is defined. There are plenty of treatments were used for these patients included biofeedback, hypnosis, occlusal splints, beside drugs. Pharmacological treatments such as Clonidine, Clonazepam, Hydroxizine, Sodium valproate, selective serotonin reuptake inhibitors (SSRIs) sometimes induce bruxism. Case reports showed that SSRIs induced bruxism resolved by Buspirone but tricyclic antidepressants were not supported to be effective treatment for bruxism in papers. It is hypothesized that the direct and indirect pathways of the basal ganglia are involved in the coordination of movements is disturbed in bruxer like in Parkinson disease. Based on these facts we had thought Trihexyphenidyl may be effective in resistant patients. This study describes 4 patients whom suffered from bruxism which resisted to usual treatments. Trihexiphenidyl (Artane) an anticholinergic drug reduced symptoms in all cases. Anticholinergic drugs can be considered for treating bruxism. Both night and day types of bruxism, as a movement disorder was relieved in response to Thp, probably due to anticholinergic effects in basal ganglia. These isolated cases could not be generalized. Further placebo controlled clinical trials are needed to evaluate and proof the efficacy of anticholinergic drugs such as Thp for treating of bruxism.},
year = {2015}
}
TY - JOUR T1 - Treatment of Bruxism with Trihexiphenidyl, a Case Series AU - Seyyed Mohammad Moosavi AU - Javad Setareh AU - Mahshid Ahmadi AU - Mani B. Monajemi AU - Soudabeh Shafiee Ardestani Y1 - 2015/10/23 PY - 2015 N1 - https://doi.org/10.11648/j.ajpn.20150306.12 DO - 10.11648/j.ajpn.20150306.12 T2 - American Journal of Psychiatry and Neuroscience JF - American Journal of Psychiatry and Neuroscience JO - American Journal of Psychiatry and Neuroscience SP - 108 EP - 110 PB - Science Publishing Group SN - 2330-426X UR - https://doi.org/10.11648/j.ajpn.20150306.12 AB - Bruxism is a sleep related movement disorder defined by repetitive jaw muscle activity that causes clenching or grinding of the teeth. Bruxism can lead to teeth and jaw damage and disturbs sleeping process. Although gastro-esophageal reflux, smoking and disturbances in CNS dopaminergic system implicated in etiology of bruxism but no clear etiology is defined. There are plenty of treatments were used for these patients included biofeedback, hypnosis, occlusal splints, beside drugs. Pharmacological treatments such as Clonidine, Clonazepam, Hydroxizine, Sodium valproate, selective serotonin reuptake inhibitors (SSRIs) sometimes induce bruxism. Case reports showed that SSRIs induced bruxism resolved by Buspirone but tricyclic antidepressants were not supported to be effective treatment for bruxism in papers. It is hypothesized that the direct and indirect pathways of the basal ganglia are involved in the coordination of movements is disturbed in bruxer like in Parkinson disease. Based on these facts we had thought Trihexyphenidyl may be effective in resistant patients. This study describes 4 patients whom suffered from bruxism which resisted to usual treatments. Trihexiphenidyl (Artane) an anticholinergic drug reduced symptoms in all cases. Anticholinergic drugs can be considered for treating bruxism. Both night and day types of bruxism, as a movement disorder was relieved in response to Thp, probably due to anticholinergic effects in basal ganglia. These isolated cases could not be generalized. Further placebo controlled clinical trials are needed to evaluate and proof the efficacy of anticholinergic drugs such as Thp for treating of bruxism. VL - 3 IS - 6 ER -
Information
Email: